×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVDL – avadel pharmaceuticals plc - ordinary share (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVDL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
12:33 pm
avdl
State-of-the-science webinar will explore narcolepsy and hypersomnia
Low
Report
State-of-the-science webinar will explore narcolepsy and hypersomnia
11/13
08:28 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at HC Wainwright from $27.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at HC Wainwright from $27.00 to $25.00. They now have a "buy" rating on the stock.
11/13
08:00 am
avdl
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Medium
Report
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/13
02:26 am
avdl
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ... [Yahoo! Finance]
High
Report
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ... [Yahoo! Finance]
11/12
03:20 pm
avdl
Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript [Seeking Alpha]
11/12
08:33 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
High
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
11/12
07:00 am
avdl
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
High
Report
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
11/11
07:33 am
avdl
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
07:00 am
avdl
avadel pharmaceuticals plc - ordinary share
BEAT
Report
-18.1%
avadel pharmaceuticals plc - ordinary share
8/8/2024
07:00 am
avdl
avadel pharmaceuticals plc - ordinary share
BEAT
Report
-1.6%
avadel pharmaceuticals plc - ordinary share
5/8/2024
07:00 am
avdl
avadel pharmaceuticals plc - ordinary share
MISS
Report
-10.6%
avadel pharmaceuticals plc - ordinary share
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
11:51 am
avdl
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
11/14
06:11 am
avdl
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: RTW INVESTMENTS, LP
Medium
Report
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: RTW INVESTMENTS, LP
11/13
05:59 pm
avdl
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Polar Capital Holdings Plc
Medium
Report
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Polar Capital Holdings Plc
11/12
09:35 am
avdl
Form 10-Q AVADEL PHARMACEUTICALS For: Sep 30
High
Report
Form 10-Q AVADEL PHARMACEUTICALS For: Sep 30
11/12
09:24 am
avdl
Form 8-K AVADEL PHARMACEUTICALS For: Nov 12
High
Report
Form 8-K AVADEL PHARMACEUTICALS For: Nov 12
11/8
02:20 pm
avdl
Form SC 13G AVADEL PHARMACEUTICALS Filed by: BlackRock, Inc.
Low
Report
Form SC 13G AVADEL PHARMACEUTICALS Filed by: BlackRock, Inc.
10/31
07:07 am
avdl
Form 8-K AVADEL PHARMACEUTICALS For: Oct 30
Medium
Report
Form 8-K AVADEL PHARMACEUTICALS For: Oct 30
10/24
02:03 pm
avdl
Form SC 13G AVADEL PHARMACEUTICALS Filed by: BlackRock, Inc.
Low
Report
Form SC 13G AVADEL PHARMACEUTICALS Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/21
Avadel Pharmaceuticals Announces $65 Million Private Placement with Leading Biotech Investment Funds
32.0%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
TOP News Decliners
3/12
Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.250 ActVsEst 0.180 - Beat
-20.7%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: